BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16454137)

  • 21. The effect of fludarabine on interferon-gamma production by lymphoid cells from healthy donors and patients with B-cell chronic lymphocytic leukemia.
    Gamberale R; Fernández-Calotti P; Sánchez-Avalos J; Alberto MF; Geffner J; Giordano M
    Haematologica; 2006 Apr; 91(4):574-6. PubMed ID: 16533725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia.
    Ural AU; Kubar A; Avcu F; Tastan HB; Safali M; Nevruz O; Cetin T
    Clin Exp Dermatol; 2007 Mar; 32(2):151-4. PubMed ID: 17244344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eosinophilia during fludarabine treatment of chronic lymphocytic leukemia.
    Sezer O; Schmid P; Hallek M; Schweigert M; Beinert T; Langelotz C; Mergenthaler HG; Possinger K
    Ann Hematol; 1999 Oct; 78(10):475-7. PubMed ID: 10550560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experience with fludarabine treatment and review of the literature].
    Telek B; Rejtó L; Kiss A; Batár P; Reményi G; Rák K; Udvardy M
    Orv Hetil; 2002 Jun; 143(24):1459-65. PubMed ID: 12138643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fludarabine-induced hemolytic anemia: successful treatment by rituximab.
    Paydas S
    Hematol J; 2004; 5(1):81-3. PubMed ID: 14745435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acquired pure red cell aplasia in a patient with B cell chronic lymphocytic leukemia after fludarabine therapy].
    Tsuji T; Hirano T; Yamasaki H; Tuda H
    Rinsho Ketsueki; 2015 Jun; 56(6):705-10. PubMed ID: 26256883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
    Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
    N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine.
    Montalban C; Liaño F; Aguilera A
    Postgrad Med J; 1994 Sep; 70(827):651-2. PubMed ID: 7971632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience with fludarabine in leukaemia.
    Keating MJ; Estey E; O'Brien S; Kantarjian H; Robertson LE; Plunkett W
    Drugs; 1994; 47 Suppl 6():39-49. PubMed ID: 7525188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term results with fludarabine monotherapy in chronic lymphocytic leukemia].
    Varga F; Lehoczky D; Demeter J
    Orv Hetil; 1999 Aug; 140(31):1731-5. PubMed ID: 10463032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia.
    Maung ZT; Wood AC; Jackson GH; Turner GE; Appleton AL; Hamilton PJ
    Br J Haematol; 1994 Nov; 88(3):649-52. PubMed ID: 7819085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fludarabine.
    Med Lett Drugs Ther; 1991 Sep; 33(853):89-90. PubMed ID: 1886506
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
    Lam CC; Ma ES; Kwong YL
    Am J Hematol; 2005 Aug; 79(4):288-90. PubMed ID: 16044456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probable autoimmune neutropenia induced by fludarabine treatment for chronic lymphocytic leukaemia.
    Stern SC; Shah S; Costello C
    Br J Haematol; 1999 Sep; 106(3):836-7. PubMed ID: 10469479
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeting base excision repair suggests a new therapeutic strategy of fludarabine for the treatment of chronic lymphocytic leukemia.
    Bulgar AD; Snell M; Donze JR; Kirkland EB; Li L; Yang S; Xu Y; Gerson SL; Liu L
    Leukemia; 2010 Oct; 24(10):1795-9. PubMed ID: 20811400
    [No Abstract]   [Full Text] [Related]  

  • 36. Fludarabine and autoimmune hemolytic anemia in chronic lymphocytic leukemia.
    Longo G; Gandini G; Ferrara L; Torelli U; Emilia G
    Eur J Haematol; 1997 Aug; 59(2):124-5. PubMed ID: 9293862
    [No Abstract]   [Full Text] [Related]  

  • 37. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine.
    Di Raimondo F; Giustolisi R; Cacciola E; O'Brien S; Kantarjian H; Robertson LB; Keating MJ
    Leuk Lymphoma; 1993 Sep; 11(1-2):63-8. PubMed ID: 8220155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
    Wells T; Kovacs MJ
    Ann Pharmacother; 2003 May; 37(5):671-4. PubMed ID: 12708944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose chlorambucil for the treatment of chronic lymphocytic leukaemia and low-grade non-Hodgkin's lymphoma.
    Summerfield GP; Taylor PR; Mounter PJ; Proctor SJ
    Br J Haematol; 2002 Mar; 116(4):781-6. PubMed ID: 11886381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence of autoimmune thrombocytopenia after treatment with fludarabine in a patient with chronic lymphocytic leukemia.
    Montillo M; Tedeschi A; Leoni P
    Leuk Lymphoma; 1994 Sep; 15(1-2):187-8. PubMed ID: 7858499
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.